BioMarin Pharmaceutical market cap
As of November 2026, BioMarin Pharmaceutical (BMRN) has a market capitalization of $11.90 B, which makes it #964 among the world’s largest public companies. Over the past year its value changed by +9.82%.
Market cap$11.90 B
World rank#964
1 year+9.82%
Share price$61.42
Market cap over time
By year
| Year | Value | Change |
|---|---|---|
| 2026 | $11.90 B | +3.35% |
| 2025 | $11.51 B | −9.58% |
| 2024 | $12.73 B | −31.8% |
| 2023 | $18.68 B | −6.83% |
| 2022 | $20.05 B | +17.1% |
| 2021 | $17.12 B | +0.75% |
| 2020 | $16.99 B | +3.71% |
| 2019 | $16.38 B | −0.70% |
| 2018 | $16.50 B | −4.51% |
| 2017 | $17.27 B | +7.64% |
| 2016 | $16.05 B | −20.9% |
| 2015 | $20.29 B | +15.9% |
Market cap history is an estimate: monthly closing price × today’s share count, in US dollars at today’s exchange rate. Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.